DBV Technologies (DBVT) Current Assets (2015 - 2026)
DBV Technologies (DBVT) posted Current Assets of $201.9 million for Q2 2026, down 18.16% sequentially from $246.7 million in Q1 2026, and up 66.53% YoY from $121.2 million in Q2 2025.
DBV Technologies (DBVT) Current Assets (2015 - 2026) Analysis & Trends
DBV Technologies has reported Current Assets for 12 years, with the latest figure at $201.9 million in Q2 2026.
- Quarterly Current Assets rose 66.53% year-over-year to $201.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $201.9 million (up 66.53% YoY) and the FY2025 annual result came in at $212.9 million, up 379.63% from the prior year.
- Current Assets eased to $201.9 million in Q2 2026 per DBVT's latest filing, from $246.7 million in the prior quarter.
- Over five years, Current Assets peaked at $260.0 million in Q2 2022 and troughed at $29.1 million in Q1 2025.
- A 5-year average of $153.1 million and a median of $164.1 million in 2023 frame the typical range for Current Assets.
- The sharpest annual moves came in 2025 and 2026: Current Assets slumped 75.62% in 2025, then soared 746.37% in 2026.
- Over 5 years, Current Assets stood at $223.1 million in 2022, then fell by 28.76% to $158.9 million in 2023, then slumped by 72.07% to $44.4 million in 2024, then surged by 379.63% to $212.9 million in 2025, then retreated by 5.17% to $201.9 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $201.9 million, $246.7 million, and $212.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | DBV Technologies | 6.08 Bn | 5.90 Bn | - | 201.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 201.90 Mn |
| Mar 31, 2026 | 246.70 Mn |
| Dec 31, 2025 | 212.90 Mn |
| Sep 30, 2025 | 88.88 Mn |
| Jun 30, 2025 | 121.24 Mn |
| Mar 31, 2025 | 29.15 Mn |
| Dec 31, 2024 | 44.39 Mn |
| Sep 30, 2024 | 68.76 Mn |
| Jun 30, 2024 | 89.96 Mn |
| Mar 31, 2024 | 119.56 Mn |
| Dec 31, 2023 | 158.92 Mn |
| Sep 30, 2023 | 169.27 Mn |
| Jun 30, 2023 | 195.54 Mn |
| Mar 31, 2023 | 210.24 Mn |
| Dec 31, 2022 | 223.07 Mn |
| Sep 30, 2022 | 225.70 Mn |
| Jun 30, 2022 | 259.95 Mn |
| Mar 31, 2022 | 90.44 Mn |
| Dec 31, 2021 | 114.39 Mn |
| Sep 30, 2021 | 110.14 Mn |